{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-3.9","upperLimit":"0.7","value":"-1.6"},{"groupId":"OG001","lowerLimit":"-6.2","upperLimit":"0.6","value":"-2.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"173"},{"groupId":"OG001","value":"80"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 4"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-4.0","upperLimit":"1.1","value":"-1.4"},{"groupId":"OG001","lowerLimit":"-7.8","upperLimit":"-0.6","value":"-4.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"144"},{"groupId":"OG001","value":"77"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 7"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-4.3","upperLimit":"1.3","value":"-1.5"},{"groupId":"OG001","lowerLimit":"-5.7","upperLimit":"2.2","value":"-1.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"128"},{"groupId":"OG001","value":"65"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 10"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-4.9","upperLimit":"0.7","value":"-2.1"},{"groupId":"OG001","lowerLimit":"-8.0","upperLimit":"-0.3","value":"-4.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"110"},{"groupId":"OG001","value":"58"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 13"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-7.0","upperLimit":"-1.1","value":"-4.0"},{"groupId":"OG001","lowerLimit":"-7.3","upperLimit":"0.8","value":"-3.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"104"},{"groupId":"OG001","value":"53"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 16"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-6.3","upperLimit":"0.5","value":"-2.9"},{"groupId":"OG001","lowerLimit":"-8.5","upperLimit":"1.0","value":"-3.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"96"},{"groupId":"OG001","value":"50"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 19"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-6.1","upperLimit":"0.5","value":"-2.8"},{"groupId":"OG001","lowerLimit":"-9.5","upperLimit":"0.1","value":"-4.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"95"},{"groupId":"OG001","value":"42"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 22"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-7.0","upperLimit":"-1.1","value":"-4.0"},{"groupId":"OG001","lowerLimit":"-8.2","upperLimit":"0.9","value":"-3.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"88"},{"groupId":"OG001","value":"34"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 25"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-5.6","upperLimit":"0.9","value":"-2.3"},{"groupId":"OG001","lowerLimit":"-11.3","upperLimit":"-1.4","value":"-6.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"34"}],"units":"Participants"}],"title":"Disease Symptoms, Week 28"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-5.9","upperLimit":"0.6","value":"-2.7"},{"groupId":"OG001","lowerLimit":"-12.1","upperLimit":"-2.2","value":"-7.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"74"},{"groupId":"OG001","value":"33"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 31"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-5.7","upperLimit":"0.2","value":"-2.8"},{"groupId":"OG001","lowerLimit":"-12.9","upperLimit":"-3.2","value":"-8.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"70"},{"groupId":"OG001","value":"24"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 34"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-9.6","upperLimit":"-2.8","value":"-6.2"},{"groupId":"OG001","lowerLimit":"-12.9","upperLimit":"-1.4","value":"-7.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"24"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 37"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-9.0","upperLimit":"-2.7","value":"-5.9"},{"groupId":"OG001","lowerLimit":"-12.3","upperLimit":"-1.3","value":"-6.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"65"},{"groupId":"OG001","value":"23"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 40"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-8.6","upperLimit":"-1.2","value":"-4.9"},{"groupId":"OG001","lowerLimit":"-15.6","upperLimit":"-1.6","value":"-8.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"18"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 43"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-10.0","upperLimit":"-4.1","value":"-7.1"},{"groupId":"OG001","lowerLimit":"-14.4","upperLimit":"-2.3","value":"-8.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"63"},{"groupId":"OG001","value":"13"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 46"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-8.9","upperLimit":"-1.9","value":"-5.4"},{"groupId":"OG001","lowerLimit":"-15.2","upperLimit":"-1.3","value":"-8.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"16"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 49"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-10.7","upperLimit":"-4.7","value":"-7.7"},{"groupId":"OG001","lowerLimit":"-15.8","upperLimit":"-4.1","value":"-10.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"17"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 52"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-11.2","upperLimit":"-3.9","value":"-7.6"},{"groupId":"OG001","lowerLimit":"-12.5","upperLimit":"1.7","value":"-5.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"59"},{"groupId":"OG001","value":"16"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 55"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-10.7","upperLimit":"-2.3","value":"-6.5"},{"groupId":"OG001","lowerLimit":"-13.6","upperLimit":"2.6","value":"-5.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"56"},{"groupId":"OG001","value":"15"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 58"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-10.6","upperLimit":"-2.4","value":"-6.5"},{"groupId":"OG001","lowerLimit":"-10.7","upperLimit":"4.4","value":"-3.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"51"},{"groupId":"OG001","value":"16"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 61"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-10.7","upperLimit":"-2.8","value":"-6.7"},{"groupId":"OG001","lowerLimit":"-16.8","upperLimit":"-2.0","value":"-9.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"49"},{"groupId":"OG001","value":"14"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 64"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-13.3","upperLimit":"-6.5","value":"-9.9"},{"groupId":"OG001","lowerLimit":"-14.1","upperLimit":"-1.7","value":"-7.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"15"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 67"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-13.8","upperLimit":"-7.6","value":"-10.7"},{"groupId":"OG001","lowerLimit":"-18.1","upperLimit":"-6.5","value":"-12.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"13"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 70"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-12.7","upperLimit":"-4.8","value":"-8.7"},{"groupId":"OG001","lowerLimit":"-13.4","upperLimit":"0.6","value":"-6.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"40"},{"groupId":"OG001","value":"14"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 73"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-11.0","upperLimit":"-3.5","value":"-7.2"},{"groupId":"OG001","lowerLimit":"-13.6","upperLimit":"-0.5","value":"-7.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"15"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 76"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-12.6","upperLimit":"-5.0","value":"-8.8"},{"groupId":"OG001","lowerLimit":"-17.1","upperLimit":"-3.8","value":"-10.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"15"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 79"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-10.5","upperLimit":"-3.2","value":"-6.9"},{"groupId":"OG001","lowerLimit":"-18.3","upperLimit":"-5.4","value":"-11.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"15"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 82"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-10.7","upperLimit":"-3.5","value":"-7.1"},{"groupId":"OG001","lowerLimit":"-19.4","upperLimit":"-6.7","value":"-13.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"12"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 85"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-10.5","upperLimit":"-2.9","value":"-6.7"},{"groupId":"OG001","lowerLimit":"-18.0","upperLimit":"-4.7","value":"-11.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"12"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 88"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-11.7","upperLimit":"-2.4","value":"-7.0"},{"groupId":"OG001","lowerLimit":"-12.0","upperLimit":"4.4","value":"-3.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"12"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 91"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-12.8","upperLimit":"-5.0","value":"-8.9"},{"groupId":"OG001","lowerLimit":"-16.2","upperLimit":"-2.0","value":"-9.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"11"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 94"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-10.6","upperLimit":"-2.1","value":"-6.4"},{"groupId":"OG001","lowerLimit":"-15.2","upperLimit":"0.0","value":"-7.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"10"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 97"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-12.7","upperLimit":"-3.0","value":"-7.8"},{"groupId":"OG001","lowerLimit":"-16.7","upperLimit":"1.6","value":"-7.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"35"},{"groupId":"OG001","value":"10"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 100"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-12.2","upperLimit":"-3.3","value":"-7.8"},{"groupId":"OG001","lowerLimit":"-13.3","upperLimit":"4.0","value":"-4.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"9"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 103"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-12.2","upperLimit":"-3.6","value":"-7.9"},{"groupId":"OG001","lowerLimit":"-16.4","upperLimit":"2.0","value":"-7.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 106"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-11.7","upperLimit":"-3.6","value":"-7.7"},{"groupId":"OG001","lowerLimit":"-14.4","upperLimit":"2.2","value":"-6.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"8"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 109"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-14.4","upperLimit":"-5.3","value":"-9.9"},{"groupId":"OG001","lowerLimit":"-10.7","upperLimit":"7.9","value":"-1.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"7"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 112"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-12.0","upperLimit":"-3.7","value":"-7.9"},{"groupId":"OG001","lowerLimit":"-13.4","upperLimit":"3.3","value":"-5.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"8"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 115"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-11.7","upperLimit":"-1.3","value":"-6.5"},{"groupId":"OG001","lowerLimit":"-13.4","upperLimit":"7.3","value":"-3.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"8"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 118"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-10.0","upperLimit":"5.3","value":"-2.3"},{"groupId":"OG001","lowerLimit":"-21.3","upperLimit":"7.8","value":"-6.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"8"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 121"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-16.1","upperLimit":"-6.5","value":"-11.3"},{"groupId":"OG001","lowerLimit":"-16.9","upperLimit":"2.3","value":"-7.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 124"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-13.2","upperLimit":"-1.8","value":"-7.5"},{"groupId":"OG001","lowerLimit":"-22.6","upperLimit":"0.7","value":"-10.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 127"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-16.0","upperLimit":"-6.9","value":"-11.5"},{"groupId":"OG001","lowerLimit":"-14.6","upperLimit":"4.5","value":"-5.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"5"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 130"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-16.0","upperLimit":"-4.4","value":"-10.2"},{"groupId":"OG001","lowerLimit":"-15.8","upperLimit":"7.5","value":"-4.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 133"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-14.8","upperLimit":"-3.1","value":"-8.9"},{"groupId":"OG001","lowerLimit":"-26.4","upperLimit":"-2.4","value":"-14.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"5"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 136"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-15.6","upperLimit":"-7.3","value":"-11.5"},{"groupId":"OG001","lowerLimit":"-22.2","upperLimit":"-5.8","value":"-14.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 139"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-17.0","upperLimit":"-6.8","value":"-11.9"},{"groupId":"OG001","lowerLimit":"-22.1","upperLimit":"-0.1","value":"-11.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"4"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 142"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-14.7","upperLimit":"-5.2","value":"-10.0"},{"groupId":"OG001","lowerLimit":"-19.3","upperLimit":"0.1","value":"-9.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"5"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 145"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-14.3","upperLimit":"-3.0","value":"-8.7"},{"groupId":"OG001","lowerLimit":"-22.5","upperLimit":"2.3","value":"-10.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"4"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 148"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-15.4","upperLimit":"-7.0","value":"-11.2"},{"groupId":"OG001","lowerLimit":"-22.6","upperLimit":"-3.3","value":"-13.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"4"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 151"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-14.9","upperLimit":"-2.8","value":"-8.8"},{"groupId":"OG001","lowerLimit":"-15.1","upperLimit":"12.1","value":"-1.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"4"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 154"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-16.5","upperLimit":"-7.1","value":"-11.8"},{"groupId":"OG001","lowerLimit":"-20.3","upperLimit":"2.1","value":"-9.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 157"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-15.2","upperLimit":"-0.9","value":"-8.0"},{"groupId":"OG001","lowerLimit":"-15.6","upperLimit":"19.2","value":"1.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 160"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-16.1","upperLimit":"-5.3","value":"-10.7"},{"groupId":"OG001","lowerLimit":"-17.9","upperLimit":"8.6","value":"-4.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 163"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-18.6","upperLimit":"-7.0","value":"-12.8"},{"groupId":"OG001","lowerLimit":"-19.8","upperLimit":"7.8","value":"-6.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 166"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-15.8","upperLimit":"-4.1","value":"-10.0"},{"groupId":"OG001","lowerLimit":"-23.3","upperLimit":"4.5","value":"-9.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 169"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-19.9","upperLimit":"-10.0","value":"-15.0"},{"groupId":"OG001","lowerLimit":"-22.1","upperLimit":"0.0","value":"-11.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 172"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-21.4","upperLimit":"-10.8","value":"-16.1"},{"groupId":"OG001","lowerLimit":"-20.6","upperLimit":"1.9","value":"-9.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 175"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-19.5","upperLimit":"-12.4","value":"-15.9"},{"groupId":"OG001","lowerLimit":"-26.2","upperLimit":"-11.5","value":"-18.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 178"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-20.6","upperLimit":"-8.3","value":"-14.5"},{"groupId":"OG001","lowerLimit":"-23.8","upperLimit":"1.7","value":"-11.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 181"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-22.2","upperLimit":"-2.5","value":"-12.4"},{"groupId":"OG001","lowerLimit":"-26.8","upperLimit":"10.6","value":"-8.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 184"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-20.2","upperLimit":"4.6","value":"-7.8"},{"groupId":"OG001","lowerLimit":"-33.4","upperLimit":"16.8","value":"-8.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 187"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-17.5","upperLimit":"4.1","value":"-6.7"},{"groupId":"OG001","lowerLimit":"-25.9","upperLimit":"15.5","value":"-5.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 190"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-22.7","upperLimit":"-5.2","value":"-14.0"},{"groupId":"OG001","lowerLimit":"-23.7","upperLimit":"1.1","value":"-11.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 193"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-24.0","upperLimit":"-15.6","value":"-19.8"},{"groupId":"OG001","lowerLimit":"-23.1","upperLimit":"-8.9","value":"-16.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 196"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-25.2","upperLimit":"1.6","value":"-11.8"},{"groupId":"OG001","lowerLimit":"-25.9","upperLimit":"10.8","value":"-7.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 199"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-26.3","upperLimit":"-9.4","value":"-17.9"},{"groupId":"OG001","lowerLimit":"-23.6","upperLimit":"3.9","value":"-9.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 202"},{"categories":[{"measurements":[{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG000","lowerLimit":"NA","upperLimit":"NA","value":"NA"},{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG001","lowerLimit":"NA","upperLimit":"NA","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 205"},{"categories":[{"measurements":[{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG000","lowerLimit":"NA","upperLimit":"NA","value":"NA"},{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG001","lowerLimit":"NA","upperLimit":"NA","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 208"},{"categories":[{"measurements":[{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG000","lowerLimit":"NA","upperLimit":"NA","value":"NA"},{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG001","lowerLimit":"NA","upperLimit":"NA","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 211"},{"categories":[{"measurements":[{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG000","lowerLimit":"NA","upperLimit":"NA","value":"NA"},{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG001","lowerLimit":"NA","upperLimit":"NA","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 214"},{"categories":[{"measurements":[{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG000","lowerLimit":"NA","upperLimit":"NA","value":"NA"},{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG001","lowerLimit":"NA","upperLimit":"NA","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 217"},{"categories":[{"measurements":[{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG000","lowerLimit":"NA","upperLimit":"NA","value":"NA"},{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG001","lowerLimit":"NA","upperLimit":"NA","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 220"},{"categories":[{"measurements":[{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG000","lowerLimit":"NA","upperLimit":"NA","value":"NA"},{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG001","lowerLimit":"NA","upperLimit":"NA","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 223"},{"categories":[{"measurements":[{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG000","lowerLimit":"NA","upperLimit":"NA","value":"NA"},{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG001","lowerLimit":"NA","upperLimit":"NA","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 226"},{"categories":[{"measurements":[{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG000","lowerLimit":"NA","upperLimit":"NA","value":"NA"},{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG001","lowerLimit":"NA","upperLimit":"NA","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 229"},{"categories":[{"measurements":[{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG000","lowerLimit":"NA","upperLimit":"NA","value":"NA"},{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG001","lowerLimit":"NA","upperLimit":"NA","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 232"},{"categories":[{"measurements":[{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG000","lowerLimit":"NA","upperLimit":"NA","value":"NA"},{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments.","groupId":"OG001","lowerLimit":"NA","upperLimit":"NA","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 235"},{"categories":[{"measurements":[{"comment":"Analysis was performed only if the number of subjects with analysable data at the current time point is \\>= 10 in total across both treatments","groupId":"OG001","lowerLimit":"NA","upperLimit":"NA","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Disease Symptoms, CFB to Week 238"}],"denoms":[{"counts":[{"groupId":"OG000","value":"218"},{"groupId":"OG001","value":"107"}],"units":"Participants"}],"description":"European Organization for Research and Treatment of Cancer Item Library 52 (EORTC-QLQ-IL52) is disease symptoms domain from EORTC Quality of Life Questionnaire 20-item Multiple Myeloma module) (EORTC QLQ-MY20). Disease symptoms domain of IL52 contain 6 items covering following concepts: bone aches or pain, back pain, hip pain, arm or shoulder pain, chest pain, and pain increasing with activity. IL52 items are scored on 1 to 4 Likert-type scale, where 1 = Not at all, 2 = A little, 3 = Quite a bit, and 4 = Very much. A raw score is then calculated as mean of completed item responses across 6 disease symptom items. For symptom scales, this raw score is linearly transformed to a 0 to 100 scale using the formula: \\[(raw score - 1) / 3\\] × 100. Under this approach, a score of 0 indicates no symptoms across items, while a score of 100 indicates the highest level of symptom burden. Accordingly, higher scores indicate greater symptom burden or worse disease symptoms","dispersionType":"95% Confidence Interval","groups":[{"description":"Participants with relapsed/refractory multiple myeloma (RRMM) received 30 minutes intravenous infusion of 2.5 milligram/kilogram (mg/kg) belantamab mafodotin on day 1 of each 21-day cycle","id":"OG000","title":"Belantamab Mafodotin"},{"description":"Participants with RRMM received 4 mg pomalidomide capsule daily on Days 1 to 21 of each 28-day cycle, along with 40 mg or at lower 20 mg (for participants \\>75 years of age) dose of dexamethasone tablet once weekly (Days 1, 8, 15 and 22)","id":"OG001","title":"Pomalidomide Plus Dexamethasone"}],"paramType":"LEAST_SQUARES_MEAN","populationDescription":"ITT Population. Only those participants who were measured and analyzed (i.e., contributed data reported in the table) were included in the Overall Number of Participants Analyzed field. 'Number Analyzed' signifies participants evaluable for the specified time points.","reportingStatus":"POSTED","timeFrame":"Baseline (Day 1), every three weeks(Q3W) starting from week 4 until week 238","title":"Change From Baseline (CFB) in EORTC IL52 Score","type":"SECONDARY","unitOfMeasure":"Scores on Scale"}